IRB.NS(IRB.NS)
IRB.NS
No analyst ratings available
No analyst price targets available for IRB.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $78.22B | $85.94B | $85.44B |
| Low | $59.90B | $62.18B | $84.13B |
| High | $85.98B | $106.53B | $86.75B |
| EBITDA Avg | $56.80B | $62.40B | $62.04B |
| Low | $43.49B | $45.15B | $61.09B |
| High | $62.43B | $77.36B | $62.99B |
| EBIT Avg | $39.95B | $43.89B | $43.63B |
| Low | $30.59B | $31.75B | $42.96B |
| High | $43.91B | $54.40B | $44.30B |
| Net Income Avg | $12.69B | $16.04B | $17.97B |
| Low | $10.15B | $14.92B | $15.08B |
| High | $13.00B | $17.05B | $21.36B |
| EPS Avg | $0.96 | $1.29 | $1.50 |
| Low | $0.84 | $1.23 | $1.24 |
| High | $1.07 | $1.40 | $1.76 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 2 / 2 |